Supply Chain
Long wait times, crowded waiting rooms, and frustrated staff are often symptoms of inefficient workflows driven by physical space constraints.…
Melville, N.Y.-based Henry Schein, the world's largest healthcare products and service supplier, completed its 50 percent equity investment in dental equipment and distributor One Piece, a division of J. Morita in Japan.
The US Food and Drug Administration recently introduced new draft guidance on Thursday, encouraging drug companies to consider quality attributes when developing chewable tablets.
The Food and Drug Administration granted emergency use authorizations for two in-vitro devices that diagnose the Zika virus.
Researchers at UCLA developed a new statistical method that provides more accurate estimates on how long a cancer patient has to live.
Here are the five latest medical devices or drugs approved by the Food and Drug Administration.
Shire, a biotech company focused on developing breakthrough therapies for rare diseases and high-need conditions, has agreed to license global rights to Pfizer's new gastrointestinal drug.
The Food and Drug Administration recently approved Philadelphia-based Lannett's neomycin sulfate tablets.
Translational Genomics Research Institute in Phoenix and Northern Arizona University in Flagstaff developed a new technology to detect antibiotic-resistant infections that just received its first patent from Australia.
The Food and Drug Administration strengthened an existing warning of the risk of acute kidney injury from the diabetes medicines canagliflozin and dipaglifozin.
The blood-brain barrier, a protective sheath surrounding the brain's blood supply, prevents more than just germs and toxins from entering the brain — it also blocks crucial medicines that could treat brain cancer.